(Q39589741)

13 September 2017

title

Pro-apoptotic role of integrin β3 in glioma cells (English)

1 reference

13 September 2017

0 references

Jong-Heon Kim

1

1 reference

13 September 2017

Long Tai Zheng

series ordinal

2

1 reference

13 September 2017

Won-Ha Lee

series ordinal

3

1 reference

13 September 2017

Kyoungho Suk

series ordinal

4

1 reference

13 September 2017

language of work or name

English

0 references

publication date

15 March 2011

1 reference

Journal of Neurochemistry

13 September 2017

published in

1 reference

13 September 2017

volume

117

1 reference

13 September 2017

issue

3

1 reference

13 September 2017

page(s)

494-503

1 reference

The dual role of nitric oxide in glioma

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

Etoposide (VP-16-213)-induced gene alterations: potential contribution to cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

Differential activation of ERKs to focal adhesions by PKC epsilon is required for PMA-induced adhesion and migration of human glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

Requirement of the NPXY motif in the integrin beta 3 subunit cytoplasmic tail for melanoma cell migration in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

The basis for current treatment recommendations for malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

Tumor necrosis factor and vascular endothelial growth factor induce endothelial integrin repertories, regulating endovascular differentiation and apoptosis in a human extravillous trophoblast cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

A Toll-like receptor 2-integrin beta3 complex senses bacterial lipopeptides via vitronectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

Comparison of cell adhesion molecule expression between glioblastoma multiforme and autologous normal brain tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

Integrin signalling during tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

Noncatalytic function of ERK1/2 can promote Raf/MEK/ERK-mediated growth arrest signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

Integrins: bidirectional, allosteric signaling machines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

Integrin regulation of cell signalling and motility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

Integrin beta3 overexpression suppresses tumor growth in a human model of gliomagenesis: implications for the role of beta3 overexpression in glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

{beta}3-integrin expression on tumor cells inhibits tumor progression, reduces metastasis, and is associated with a favorable prognosis in patients with ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

A signaling pathway from the alpha5beta1 and alpha(v)beta3 integrins that elevates bcl-2 transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

Altered adhesion properties and alphav integrin expression in a cisplatin-resistant human ovarian carcinoma cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

Prostate cancer specific integrin alphavbeta3 modulates bone metastatic growth and tissue remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

Direct binding of integrin alphavbeta3 to FGF1 plays a role in FGF1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

Integrins induce activation of EGF receptor: role in MAP kinase induction and adhesion-dependent cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

VEGF Stimulates the ERK 1/2 signaling pathway and apoptosis in cerebral endothelial cells after ischemic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

FAK signaling in anaplastic astrocytoma and glioblastoma tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

Basement membrane invasion of glioma cells mediated by integrin receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

Ligand binding to integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

Role of the alpha v beta 3 integrin in human melanoma cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

A proapoptotic signaling pathway involving RasGRP, Erk, and Bim in B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin alphaVbeta3 during angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

Increased primary tumor growth in mice null for beta3- or beta3/beta5-integrins or selectins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

The nitric oxide-sensitive p21Ras-ERK pathway mediates S-nitrosoglutathione-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

Selective opening of the blood—brain barrier by a nitric oxide donor and long-term survival in rats with C6 gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

Growth inhibition and chemosensitization of exogenous nitric oxide released from NONOates in glioma cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

Molecular determinants of glioma cell migration and invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

NO-mediated chemoresistance in C6 glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

Nitric oxide and BCNU chemoresistance in C6 glioma cells: role of S-nitrosoglutathione

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

Nitric oxide donors attenuate clongenic potential in rat C6 glioma cells treated with alkylating chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

Down-regulation of lipocalin 2 contributes to chemoresistance in glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

Alpha6 beta4 and alpha6 beta1 integrins in astrocytomas and other CNS tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2011.07219.X

10.1111/J.1471-4159.2011.07219.X

21 January 2018

Identifiers

DOI

1 reference

release_36qhiccxkbg6jbcnk4rf35kske

13 September 2017

Fatcat ID

0 references

1 reference